Lv1
20 积分 2025-08-28 加入
Therapeutic effects and associated adverse events of PD-1 and CTLA-4 pathway inhibitors in the treatment of non-small-cell lung cancer : meta-analyses of clinical phase II / III randomized controlled trials
1个月前
已关闭
Frontline anti-PD-1/PD-L1 Versus Bevacizumab in Advanced Non-Small-Cell Lung Cancer: A Network Meta-Analysis
1个月前
已完结
Frontline anti-PD-1/PD-L1 Versus Bevacizumab in Advanced Non-Small-Cell Lung Cancer: A Network Meta-Analysis
1个月前
已关闭
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
1个月前
已完结
Adverse reactions associated with systemic polymyxin therapy. Pharmacotherapy
1个月前
已完结
Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia
2个月前
已完结
Efficacy of PD-1/L1 inhibitors in brain metastases of non-small-cell lung cancer: pooled analysis from seven randomized controlled trials
2个月前
已完结
Efficacy of PD-1/L1 Inhibitors in Brain Metastases of Non-Small-Cell Lung Cancer: Pooled Analysis from Seven Randomized Controlled Trials
2个月前
已关闭
皖公网安备34019202002308
